One-year mammography follow-up falls short
Women with diagnostic mammograms flagged as probably benign usually undergo short-interval follow-up. But at 12 months, this second look may not boost cancer detection.
Women with diagnostic mammograms flagged as probably benign usually undergo short-interval follow-up. But at 12 months, this second look may not boost cancer detection.
Erin Aiello Bowles, a research associate at the Group Health Center for Health Studies in Seattle, and colleagues at several U.S. institutions evaluated the accuracy of short-interval follow-up using data from the Breast Cancer Surveillance Consortium.
Their data set included 45,007 mostly asymptomatic women aged 40 to 59 who underwent short-interval follow-up between 1994 and 2004. The investigators found that the sensitivity of mammography to detect cancer declined from 83.3% at six months to 60.5% at 12 months. They speculate that cancers assessed as probably benign (BI-RADS category 3) may not grow as rapidly as lesions that appear more suspicious for malignancy and could, therefore, mislead radiologists. They published their findings in the May American Journal of Roentgenology.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
